Methylphenidate in children with monogenic obesity due to LEPR or MC4R deficiency improves feeling of satiety and reduces BMI-SDS-A case series

Erstveröffentlichung
2020Authors
Brandt, Stephanie
von Schnurbein, Julia
Lennerz, Belinda
Kohlsdorf, Katja
Vollbach, Heike
Wissenschaftlicher Artikel
Published in
Pediatric Obesity ; 15 (2020), 1. - Art.-Nr. e12577. - ISSN 2047-6310. - eISSN 2047-6302
Link to publication
https://dx.doi.org/10.1111/ijpo.12577Institutions
UKU. Klinik für Kinder- und JugendmedizinSubject headings
[Free subject headings]: central nervous system | MC4R mutation | methylphenidate | monogenic obesity | LEPR mutation | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | MELANOCYTE-STIMULATING HORMONE | LEPTIN THERAPY | NEUROPEPTIDE-Y | Z-SCORES | WEIGHT | DOPAMINE | GROWTH | HEIGHT | ONSET[DDC subject group]: DDC 610 / Medicine & health